Transom-Backed Gene Juarez Salons & Spas Appoints Lyndie Moore as Chief Executive Officer to Lead Next Phase of Growth

Transom-Backed Gene Juarez Salons & Spas Appoints Lyndie Moore as Chief Executive Officer to Lead Next Phase of Growth GlobeNewswire October 23, 2025 SEATTLE, Oct. 23, 2025 (GLOBE NEWSWIRE) — Gene Juarez Salons & Spas, the Pacific Northwest's premier luxury beauty and wellness brand, today announced the appointment of Lyndie Moore as its new Chief […]

Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025

Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 23, 2025 PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss financial

Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community

Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community GlobeNewswire October 23, 2025 PORTLAND, Tenn., Oct. 23, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a global leader in electrical balance of systems (“EBOS”) solutions for the energy transition market, announced today its participation in

Tecnoglass Sets Date for Third Quarter 2025 Results

Tecnoglass Sets Date for Third Quarter 2025 Results GlobeNewswire October 23, 2025 Miami, FL, Oct. 23, 2025 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial results

Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025

Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 23, 2025 JUPITER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. The company will hold a conference call beginning at 8:30

Stanley Steemer Supports Seasonal Wellness with Whole-Home UV Air Purification for Cleaner, Healthier Air

Stanley Steemer Supports Seasonal Wellness with Whole-Home UV Air Purification for Cleaner, Healthier Air Fight viruses, bacteria and buildup in your home's air with continuous, chemical-free purification. GlobeNewswire October 23, 2025 Dublin, OH, Oct. 23, 2025 (GLOBE NEWSWIRE) — As temperatures drop and families spend more time indoors, Stanley Steemer, the leader in professional deep

Announcing the 2025 Fortune Best Workplaces for Women

Announcing the 2025 Fortune Best Workplaces for Women Companies were selected as part of a rigorous survey of more than 600,000 women in the U.S. workforce. GlobeNewswire October 23, 2025 Oakland, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Great Place To Work(R) and Fortune have released the winners of the 2025 Fortune Best Workplaces for

Amphista Therapeutics announces three key strategic leadership appointments to drive transition of its Targeted Glue(TM) protein degraders into clinical development

Amphista Therapeutics announces three key strategic leadership appointments to drive transition of its Targeted Glue(TM) protein degraders into clinical development GlobeNewswire October 23, 2025 Appointments for SVP of Clinical Operations, VP of Translational Science, and Head of Project and Portfolio Management will strengthen Amphista's clinical development capabilities and accelerate its ambition to bring its innovative

TRIDENT, a dedicated stroke outcomes trial in patients with a history of intracerebral hemorrhage (ICH), demonstrates the potential advantages of intensive blood pressure treatment with low-dose triple combination therapyTRIDENT, a dedicate

TRIDENT, a dedicated stroke outcomes trial in patients with a history of intracerebral hemorrhage (ICH), demonstrates the potential advantages of intensive blood pressure treatment with low-dose triple combination therapyTRIDENT, a dedicate GlobeNewswire October 23, 2025 GMRx2 significantly reduced the risk of recurrent stroke when added to standard of care compared to placebo Trial results were

Marex Group Plc to Announce Third Quarter 2025 Earnings on November 6, 2025

Marex Group Plc to Announce Third Quarter 2025 Earnings on November 6, 2025 GlobeNewswire October 23, 2025 NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) — Marex Group plc (NASDAQ: MRX) today announced that it will release its fiscal 2025 third quarter results before market open on Thursday, November 6, 2025. The earnings release and supplementary

Scroll to Top